UPDATE : Tuesday, August 11, 2020
[Exclusive] Thailand recalls Medytox’s botulinum toxin
The Thai government not only suspended the sale of Meditoxin, a botulinum t...
by Jeong Sae-im  |  2020-05-21 12:33
SK’s offshoot picked as major raw material supplier to US
SK Holdings said Wednesday its active drug ingredient maker, AMPAC Fine Che...
by Shim Hyun-tai  |  2020-05-20 18:32
Eisai Korea expands indication for epilepsy treatment
Eisai Korea said that it has received an expanded indication for Fycompa, a...
by Lee Han-soo  |  2020-05-20 17:11
Hungary OKs Aptabio's P2 trial for diabetic nephropathy treatment
Aptabio said that the Hungarian health authorities have approved its invest...
by Lee Han-soo  |  2020-05-20 15:41
Drugmakers brief development progress of Covid-19 treatments at ‘Bio Korea 2020’
Biopharmaceutical companies introduced their development progress of Covid-...
by Shim Hyun-tai  |  2020-05-19 17:54
ISU Abxis releases preclinical trial results for anticancer antibody
ISU Abxis has presented the preclinical trial results for ISU104, an anti-E...
by Lee Han-soo  |  2020-05-18 15:19
SK Bioscience gets Gates Foundation's fund to develop Covid-19 vaccine
SK Bioscience said it has won the Bill & Melinda Gates Foundation's res...
by Lee Han-soo  |  2020-05-18 14:53
GC Pharma to supply Covid-19 treatment for free
GC Pharma said that it would provide GC5131A, the world's first plasma ...
by Lee Han-soo  |  2020-05-18 11:36
Medytox’s earnings plummet amid lawsuit against Daewoong
Medytox, the nation’s largest botulinum toxin maker by market share, suffer...
by Jeong Sae-im  |  2020-05-18 11:33
‘Many shareholders suffered from Medytox’s public notice of false information’
OhKims Law and Company is recruiting investors for its second suit against ...
by Shim Hyun-tai  |  2020-05-15 17:40
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
Hanmi Pharmaceutical’s diabetes drug candidate efpeglenatide, which had led...
by Jeong Sae-im  |  2020-05-15 13:14
‘Lynparza extended survival of ovarian cancer patients’
AstraZeneca said Lynparza (ingredient: olaparib) has become the first poly ...
by Kim Yun-mi  |  2020-05-14 15:14
Sanofi’s return of rights on efpeglenatide perplexes Hanmi
Hanmi Pharmaceutical said Thursday that Sanofi informed it of intention to ...
by Lee Han-soo  |  2020-05-14 10:48
GC Wellbeing’s placenta injection shows efficacy on Covid-19
GC Wellbeing, in collaboration with the research team of the Chungbuk Natio...
by Lee Han-soo  |  2020-05-13 16:02
Huons Global to confirm BTX efficacy in treating square jaws
Huons Global said that the Ministry of Food and Drug Safety has given it th...
by Lee Han-soo  |  2020-05-13 15:45
AZ, Takeda use different strategies on ovarian cancer
AstraZeneca’s Lynparza (ingredient: olaparib) and Takeda’s Zejula (nirapari...
by Kim Yun-mi  |  2020-05-13 12:34
Enzychem Lifesciences to start P2 trial of Covid-19 treatment
Enzychem Lifesciences said that the Ministry of Food and Drug Safety has ap...
by Lee Han-soo  |  2020-05-13 11:14
YD Life Science proves efficacy of diabetic treatment
YD Life Science said that it has confirmed the efficacy of YD-312, a diabet...
by Lee Han-soo  |  2020-05-13 11:14
Hugel names new CEO of its US offshoot
Hugel said Monday that it has appointed James P. Hartman as the new CEO of ...
by Lee Han-soo  |  2020-05-12 17:32
SK Biopharmaceuticals launches epilepsy drug in US
SK Biopharmaceuticals said that it has launched Xcopri, a treatment for par...
by Lee Han-soo  |  2020-05-12 16:30
Back to Top